Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Revelation Biosciences Inc (NQ: REVB ) 0.9700 -0.0900 (-8.49%) Streaming Delayed Price Updated: 2:36 PM EDT, Sep 4, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Revelation Biosciences Inc < Previous 1 2 Next > Revelation Biosciences Inc. Announces Mandatory Unit Separation to Occur on January 13, 2023 January 10, 2023 From Revelation Biosciences Inc. Via Business Wire Revelation Biosciences Inc. Announces Future Clinical Development Plans Based on Recent Biomarker Analysis and Significant Reduction in New Collagen Deposition (Fibrosis) in Preclinical Model November 18, 2022 From Revelation Biosciences Inc. Via Business Wire Revelation Biosciences Inc. Announces Financial Results for the Three and Nine Months Ended September 30, 2022 and Recent Corporate Progress November 10, 2022 From Revelation Biosciences Inc. Via Business Wire Revelation Biosciences Inc. Announces Positive Results in Preclinical Model of Acute and Chronic Kidney Disease October 25, 2022 From Revelation Biosciences Inc. Via Business Wire Revelation Biosciences Inc. and Vanderbilt University Enter Exclusive Worldwide License Agreement October 06, 2022 From Revelation Biosciences Inc. Via Business Wire InvestorNewsBreaks – Revelation Biosciences Inc. (NASDAQ: REVB) Closes $5M Public Offering August 05, 2022 Via Investor Brand Network Revelation Biosciences Inc. Announces Pricing of $5 Million Public Offering July 26, 2022 From Revelation Biosciences, Inc. Via GlobeNewswire Optimism Builds for Promising Developments & New Drug Therapies Targeting Treatments for Breast Cancer March 24, 2022 Palm Beach, FL – March 24, 2022 – FinancialNewsMedia.com News Commentary – The status of breast cancer as one of the most commonly occurring cancers in the world is expected to be a key driving factor... Via FinancialNewsMedia InvestorNewsBreaks – Revelation Biosciences Inc. (NASDAQ: REVB) Closes $7.8M PIPE Offering February 08, 2022 Via Investor Brand Network < Previous 1 2 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.